The vaccine and the antibody against VSR will be incorporated in Sus, announces the Ministry of Health

VSR is responsible for about 80% of the cases of bronchiolitis in children under the age of two

THE Ministry of Health announced on the morning of Tuesday 18, that two new alternatives for the prevention of Sincese respiratory virus (VSR)One of the main causes of serious respiratory infections in children will be incorporated Unified Health System (Sus).

VSR is responsible for about 80% of the cases of bronchiolitis and up to 60% of the pneumonia in children under the age of two. SM should publish a decree that formalizes incorporation in the next few days.

The approved technologies are Pfizer Abizer vaccine and the monochlonal antibodor Beyfortus (Nrysevimab) of Sanofi. “The introduction of these technologies represents significant progress in the protection of our children, with a reduction of hospitalizations in the face of the high number of cases. It is a milestone in our immunization policy and in the treatment of women and children in pregnancy, “Said Nísia Trindade, Minister of Health, in a press release.

The Pfizer vaccine is applied to pregnant women with 24-66 weeks of gestation. With the application to the mother, the child was born protected and remains with antibodies against the virus up to six months of age. Sanofi’s product is applied to infants and children up to 24 months. In Sus, it will be available for premature or comorbid children.

Second National Commission for the incorporation of technologies in the Unified Health System (CONITEC)The pregnant woman can prevent about 28,000 hospitalizations per year. The combined strategy will protect about 2 million children in the first months of life, when more susceptible to complications.

Last Thursday, 13, the two technologies had already been recommended by CONITEC be incorporated into the Sus. In EstodãoGuillaume Pierart, director of the Sanofi vaccine, said that approval would be “a big step towards pediatric health in Brazil – the first to build a real paradigm shift. Both data from clinical studies and real life results we see Already in countries that already use it already in countries that already use it brings robust tests of this potential.

Also in EstodãoAdriana Ribeiro, gynecologist and medical director of Pfizer, mentioned a great positive impact. “Today, 70% of the deaths (of VSR) occurs in healthy children. With the vaccine, these children were born protected, avoiding hospitalizations and deaths.”

“The virus is the main cause of death in children and is highly contagious. It is estimated that it is responsible from 66 thousand to 199 thousand deaths per year in the children of the world. By protecting these children, we have reduced the impact on the health system , which suffers from saturation of ICU pediatric during the peaks of the disease, “he adds.

Source: Terra

Ben

Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.